Published in Lancet on September 04, 1971
Ischaemic papillopathy. Clinical and fluorescein aniographic review of forty cases. Br J Ophthalmol (1974) 3.56
Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy. Eye (Lond) (2014) 0.96
Retinal artery occlusion in migraine. Postgrad Med J (1985) 0.89
Anterior ischemic optic neuropathy: diagnosis and management. Bull N Y Acad Med (1980) 0.87
Anterior ischaemic optic neuropathy. A correlative clinical and visual evoked potential study of 18 patients. J Neurol Neurosurg Psychiatry (1986) 0.78
Bilateral cilio-retinal artery occlusion in classic migraine. Postgrad Med J (1991) 0.76
New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol (1983) 26.67
Delayed visual evoked response in optic neuritis. Lancet (1972) 6.11
Visual evoked response in diagnosis of multiple sclerosis. Br Med J (1973) 5.61
Diagnosis and classification of multiple sclerosis. Br Med Bull (1977) 4.68
Oral contraceptives and cerebral arterial occlusion. Br Med J (1965) 4.42
Ischaemic papillopathy. Clinical and fluorescein aniographic review of forty cases. Br J Ophthalmol (1974) 3.56
The effects of experimental demyelination on conduction in the central nervous system. Brain (1970) 3.31
The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain (1987) 3.15
Central nervous system sarcoidosis--diagnosis and management. QJM (1999) 3.11
The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain (1995) 2.94
Visual capacity in the hemianopic field following a restricted occipital ablation. Brain (1974) 2.92
Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain (1992) 2.62
Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain (1996) 2.54
Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain (1990) 2.53
Benign retinal vasculitis. Clinical and fluorescein angiographic study. Br J Ophthalmol (1971) 2.32
Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain (1988) 2.29
Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol (1991) 2.25
Factors influencing the risk of multiple sclerosis developing in patients with optic neuritis. Brain (1978) 2.19
Viscosity and retinal vein thrombosis. Br J Ophthalmol (1976) 2.12
Fluorescein fundus photography in the detection of early papilloedema and its differentiation from pseudo-papilloedema. Lancet (1965) 2.12
Hypoxic ocular sequelae of carotid-cavernous fistulae. Study of the caues of visual failure before and after neurosurgical treatment in a series of 25 cases. Br J Ophthalmol (1969) 2.11
The pattern-evoked potential in compression of the anterior visual pathways. Brain (1976) 2.07
The clinical picture of ectasia of the intracerebral arteries. J Neurol Neurosurg Psychiatry (1982) 2.05
Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry (1996) 2.02
Acute disseminated encephalomyelitis. MRI findings and the distinction from multiple sclerosis. Brain (1990) 2.00
Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. BMJ (1990) 1.99
The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain (1998) 1.99
A neurovisceral storage disease with vertical supranuclear ophthalmoplegia, and its relationship to Niemann-Pick disease. A report of nine patients. Brain (1973) 1.94
Magnetic resonance imaging in isolated noncompressive spinal cord syndromes. Ann Neurol (1987) 1.93
Factors affecting visual loss in benign intracranial hypertension. Ophthalmology (1984) 1.89
Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology (1993) 1.87
Proton magnetic resonance spectroscopy of an acute and chronic lesion in multiple sclerosis. Lancet (1991) 1.86
Primary progressive multiple sclerosis. Brain (1997) 1.80
Ophthalmologic findings in 70 patients with evidence of retinal embolism. Ophthalmology (1982) 1.79
Computer assisted tomography in orbital disease. Br J Ophthalmol (1974) 1.79
Ischaemic papillopathy. Trans Ophthalmol Soc U K (1971) 1.79
B-lymphocyte alloantigens associated with multiple sclerosis. Lancet (1976) 1.73
Pathophysiology of demyelinating disease. Br Med Bull (1977) 1.70
Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. Brain (1996) 1.69
Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain (1994) 1.68
Anti-retinal autoimmunity and circulating immune complexes in patients with retinal vasculitis. Lancet (1982) 1.68
Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol (2000) 1.66
The significance of the association between HLA and multiple sclerosis. Br Med Bull (1978) 1.65
Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis. Neurology (1998) 1.62
Fluorescein angiography in the diagnosis of drusen of the disc. Trans Ophthalmol Soc U K (1967) 1.62
Transient uniocular visual loss on deviation of the eye in association with intraorbital tumours. J Neurol Neurosurg Psychiatry (1987) 1.61
Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology (1994) 1.60
High field MRI correlates of myelin content and axonal density in multiple sclerosis--a post-mortem study of the spinal cord. J Neurol (2003) 1.59
Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination. Neurology (1999) 1.58
The symptomatology of tumours of the anterior visual pathways. Can J Neurol Sci (1982) 1.56
Extensive neurological damage after cannulation of internal jugular vein. Br Med J (1974) 1.55
Retinal venous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis. Brain (1987) 1.54
Does the extent of axonal loss and demyelination from chronic lesions in multiple sclerosis correlate with the clinical subgroup? J Neurol Neurosurg Psychiatry (1999) 1.53
A comparison of the pathology of primary and secondary progressive multiple sclerosis. Brain (1994) 1.53
Serial magnetization transfer imaging to characterize the early evolution of new MS lesions. Neurology (1998) 1.53
Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain (1995) 1.53
Bilateral optic neuritis. A long-term follow-up. Brain (1984) 1.52
Fundus changes in histologically confirmed sarcoidosis. Br J Ophthalmol (1981) 1.52
Central remyelination restores secure conduction. Nature (1979) 1.50
Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients. J Neurol Sci (1981) 1.49
Delayed pattern-evoked responses in optic neuritis in relation to visual acuity. Trans Ophthalmol Soc U K (1973) 1.49
Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement. Neurology (1990) 1.47
Magnetic resonance imaging of the optic nerve in optic neuritis. Neurology (1988) 1.46
Ophthalmoplegia in carotid cavernous sinus fistula. Br J Ophthalmol (1984) 1.43
Retinal vasculitis: a review. J R Soc Med (1979) 1.41
Oligoclonal immunoglobulins and plasma cells in spinal fluid of patients with multiple sclerosis. Br Med J (1979) 1.41
Retinal, choroidal, and optic disc involvement in sarcoidosis. Trans Ophthalmol Soc U K (1976) 1.41
Bilateral sudden visual loss due to sphenoid mucocele in Albright's syndrome. Br J Ophthalmol (1995) 1.40
Deficient learning and memory in early and middle phases of multiple sclerosis. J Neurol Neurosurg Psychiatry (1984) 1.40
Ocular changes in limited forms of Wegener's granulomatosis. Br J Ophthalmol (1981) 1.39
New treatments for multiple sclerosis. BMJ (1995) 1.37
Bromocriptine in management of large pituitary tumours. Br Med J (Clin Res Ed) (1982) 1.36
A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up. J Neurol Neurosurg Psychiatry (1987) 1.35
Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann Neurol (1994) 1.35
The restoration of conduction by central remyelination. Brain (1981) 1.34
Multiple sclerosis: diagnostic optimism. BMJ (1992) 1.33
"Blindsight": Vision in a field defect. Lancet (1974) 1.32
Brain and spinal cord MRI in motor neuron disease. J Neurol Neurosurg Psychiatry (1996) 1.32
The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology (1999) 1.31
The longstanding MS lesion. A quantitative MRI and electron microscopic study. Brain (1991) 1.30
EDMUS, a European database for multiple sclerosis. J Neurol Neurosurg Psychiatry (1992) 1.29
Papilledema and asymptomatic intracranial hypertension in systemic lupus erythematosus. A fluorescein angiographic study of resolving papilledema. Arch Ophthalmol (1968) 1.29
Severely threatening events and marked life difficulties preceding onset or exacerbation of multiple sclerosis. J Neurol Neurosurg Psychiatry (1989) 1.29
Remyelination during optic nerve compression. J Neurol Sci (1980) 1.27
Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination. Brain (1987) 1.27
Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue. Brain (1991) 1.26
The early risk of multiple sclerosis after optic neuritis. J Neurol Neurosurg Psychiatry (1988) 1.26
Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis. Neurology (1996) 1.25
Spontaneous and mechanically evoked activity due to central demyelinating lesion. Nature (1980) 1.25
Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques. Magn Reson Imaging (1996) 1.25
Effects of x-radiation on the spinal cord: an experimental study of the morphological changes in central nerve fibres. Brain (1976) 1.24
Autosomal dominant cerebellar ataxia with pigmentary macular dystrophy. A clinical and genetic study of eight families. Brain (1994) 1.22
The mystery of the origin of multiple sclerosis. J Neurol Neurosurg Psychiatry (1986) 1.21
High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect. J Neurol Neurosurg Psychiatry (1992) 1.21
The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease. Philos Trans R Soc Lond B Biol Sci (1999) 1.21
Remyelination in the spinal cord of the cat following intraspinal injections of lysolecithin. J Neurol Sci (1977) 1.20
Amaurosis fugax: some aspects of management. J Neurol Neurosurg Psychiatry (1982) 1.20
Bilateral simultaneous optic neuropathy in adults: clinical, imaging, serological, and genetic studies. J Neurol Neurosurg Psychiatry (1995) 1.20